Lesion Change Visualization with LesionQuant 2.3

Did you know that the LesionQuant module offers lesion change visualization images?

Lesion change visualization is available when a current and prior LesionQuant study have been processed and are available in the system. Change values of lesions are determined by using both 3D T1 and (2D or 3D) T2 FLAIR MRIs.

Similar to a heat map, regions are color-coded to identify increasing and decreasing image intensities between the current and prior scans.

  • Cyan/Dark blue indicates decreasing intensity, which may indicate decreasing lesion activity
  • Orange/Red indicates increasing intensity, which may indicate increasing lesion activity
  • Areas with no change in intensity are not colored

Cortechs.ai | Lesion Change Visualization with LesionQuant 2.3

Reproducibility and Comparison Best Practices:
It is best practice to perform the current MRI on the same MRI scanner and series protocol as the prior MRI. If different scanners and/or protocols are used, caution should be taken when interpreting the results.

When patient data is already in the system:
If an earlier scan for the patient has been processed by LesionQuant (same software version) and is available in the system, change volume images are automatically included in the output sent to the PACS/DICOM Viewer. The PatientID must match on both time points, and the StudyInstanceUID must match on the individual T1/FLAIR pair.

When patient data is no longer in the system or there has been a change in the software version from the current scan:
To obtain the change visualization, the user must reprocess the original scan pair, then send the new scan pair for processing to receive the change analysis and volumes. The PatientID must match on both time points, and the StudyInstanceUID must match on the individual T1/FLAIR pair.

More Resources

03/20/2025

Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East

We are pleased to announce a strategic distribution partnership with Medical Horizons, a premier AI-powered medical device distributor based in Florence, Italy.

03/18/2025

Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring

Unlock the power of AI-driven imaging with NeuroQuant® MS—enhancing lesion detection, monitoring, and personalized care for Multiple Sclerosis.

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists
Scroll to Top